Cyclodextrins in Cosmetics

Novel Cosmetic Delivery Systems

Volumn , Issue , 2023, Pages 275-293

  Duchene, Dominique ^a   Wouessidjewe, Denis ^b   Poelman, Marie Christine ^c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIV GRENOBLE ALPES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85168524246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781003418078-14     Document Type: Chapter

References (113)

1. Villiers A. Sur la fermentation de la fécule par l’action du ferment butyrique. C R Acad Sci 1891; 112:536.
2. Schardinger F. Über thermophile Bakterien aus verschiedenen Speisen und Milch, sowie über einige Umsetzungsprodukte derselben in kohlenhydrathalien Nährolö- sungen, darunter krystallisierte Polysaccharide (Dextrine) aus Stärke. Z Unters Nahrungs-Genußmittel Gebrauchsgegenstände 1903; 6:865.
3. Schardinger F. Mitteilung aus der staatlichen Untcrsuchungsanstalt für Lebensmittel in Wien, Azetongärung. Wien Klin Wochenschr 1991; 17:207.
4. Schardinger F. Bildung kristallisierter Polysaccharide (Dextrine) aus Stärkekleister durch Mikrobien. Zentralbl Bakteriol Parasitenk Infektionskr 1911; 1129:188.
5. Vaution C, Hutin M, Glomot F, Duchêne D. The use of cyclodextrins in various industries. In: Duchêne D, ed. Cyclodextrins and Their Industrial Uses. Paris: Editions de Santé, 1987:299–350.
6. Duchêne D, Debruères B, Brćtillon A. Les cyclodextrines. Nature, origine et intérêt en pharmacie galénique. Labo-Pharma Probl Tech 1984; 32:842.
7. Duchêne D, Wouessidjewe D. Physicochemical characteristics and pharmaceutical uses of cyclodextrin derivatives. Pharm Techn Int 1990; 2(2):21.
8. Schmid G. Preparation and application of γ-cyclodextrin. In: Duchêne D, ed. New Trends in Cyclodextrins and Derivatives. Paris: Editions de Santé, 1991:188.
9. Uekama K. Pharmaceutical applications of methylated cyclodextrins. Pharm Int 1985; 6:61.
10. Uekama K, Irte T. Pharmaceutical applications of methylated cyclodextrin derivatives. In: Duchêne D, ed. Cyclodextrins and Their Industrial Uses Paris: Editions de Santé 1987:393.
11. Yoshida A, Yamamoto M, Irie T, Hirayama F, Uekama K. Some pharmaceutical properties of 3-hydroxypropyl and 2,3-dihydroxypropyl β-cyclodextrins and their solubilizing and stabilizing abilities. Chem Pharm Bull 1989; 37:1059.
12. Koizumi K, Okada Y, Kubota Y, Utamara T. Inclusion complexes of poorly watersoluble drugs with glucosyl-cyclodextrins. Chem Pharm Bull 1987; 35:3413.
13. Yamamoto M, Yoshida A, Hirayama F, Uekama K. Some physicochemical properties of branched β-cyclodextrins and their inclusion characteristics. Int J Pharm 1989; 49:163.
14. Yoshida A, Arima K, Uekama K, Pitha J. Pharmaceutical evaluation of hydroxyal-kyl ethers of β-cyclodextrins. Int J Pharm 1988; 46:217.
15. Stella RA, Stella VJ. Pharmaceutical applications of cyclodextrins, 2, In vivo drug delivery. J Pharm Sci 1996; 85:1142.
16. Szejtli J. Highly soluble β-cyclodextrin derivatives. Starch/Stärke 1984; 36:429.
17. Duchêne D. New trends in pharmaceutical applications of cyclodextrin inclusion compounds. In: Huber O, Szejtli J, eds. Proceedings of the 4th international Symposium on Cyclodextrins. Dordrecht Boston London: Kluwer, 1988:265–375.
18. Gal-Füzy M, Szente L, Szejtli J, Harangi J. Cyclodextrin-stabilized volatile substances for inhalation therapy. Pharmazie 1984; 39:558.
19. Szejtli J, Szente L, Bánky-Elöd E. Molecular encapsulation of volatile easily oxidizable labile flavour substances by cyclodextrins. Acta Chim Acad Sci Hung 1979; 101:27.
20. Uekama K, Oh K, Irie T, Otagiri M, Nishimiya Y, Nara T. Stabilization of isosorbite 5-mononitrate in solid state by β-cyclodextrin complexation. Int J Pharm 1985; 25:339.
21. Duchêne D, Debruères B, Vaution C. Improvement of drug stability by cyclodextrin inclusion complexation. STP Pharma 1985; 1:37.
22. Szejtli J, Bolla-Pusztai É, Szabó P, Ferenczy T. Enhancement of stability and biological effect of cholecalciferol by β-cyclodextrin complexation. Pharmazie 1980; 35:779.
23. Glomot F, Benkerrour L, Duchêne D, Poelman M-C. Improvement in availability and stability of a dermocorticoid by inclusion in β-cylodextrin. Int J Pharm 1988; 46:49.
24. Szejtli J. Cyclodextrins in foods, cosmetics and toiletries. In: Szejtli J. ed. Proceedings of the first international symposium on cyclodextrins. Budapest: Akadémiai Kiadó, 1982:469.
25. Fujioka K, Kurosaky Y, Sato S, Noguchi Te, Nogichi Та, Yamahira Y. Biopharmaceutical study on inclusion complexes: I. Pharmaceutical advantages of cyclodextrin complexes of bencyclane fymarate. Chem Pharm Bull 1983; 31:2416.
26. Lin S-Z, Wouessidjewe D, Poelman M-C, Duchêne D. In vivo evaluation of indomethacin/cyclodextrin complexes, Gastrointestinal tolerance and dermal antiinflammatory activity. Int J Pharm 1994; 106:63.
27. Amdidouche D, Montassier P, Poelman M-C, Duchêne D. Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β- cyclodextrin complexation. Int J Pharm 1994; 111:111.
28. Duchêne D, Wouessidjew D, Poelman M-C. Dermal uses of cyclodextrins and derivatives. In: Duchêne D, ed. New Trends in Cyclodextrins and Derivatives Paris: Editions de Santé, 1991:449.
29. Duchêne D, Wouessidjewe D, Poelman M-C. Les cyclodextrines dans les préparations pour usage dermique. In: Seiller M, Martini M-C, eds. Formes Pharmaceutiques pour Application Locale. Paris: Lavoisier Tec Doc, 1996:481.
30. Uekama K, Irie T, Sunada M, Otagiri M, Arimatsu Y, Nomura S. Alleviation of prochlorperazine-induced primary irritation of skin by cyclodextrin complexation. Chem Pharm Bull 1982; 30:3860.
31. Irie T, Otagiri M, Sunada M, Uekama K, Ohtani Y, Yamada Y, Sugiyama Y. Cyclodextrin induced hemolysis and shape changes on human erythrocytes in vitro. J Pharmacobio-Dyn 1982; 5:741.
32. Okamoto H, Komatsu H, Hashida M, Sezaki H. Effects of β-cyclodextrin and di- O-methyl β-cyclodextrin on the percutaneous absorption of butyl paraben, indomethacin and sulfanilic acid. Int J Pharm 1986; 30:35.
33. Othani Y, Irie T, Uekama K, Fukunaga K, Pitha J. Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur J Biochem 1989; 186:17.
34. Yoshida A, Yamamoto M, Irie T, Hirayama F, Uekama K. Some pharmaceutical properties of 3-hydroxypropyl and 2,3-dihydroxypropyl β-cyclodextrins and their solubilizing and stabilizing abilities. Chem Pharm Bull 1989; 37:1059.
35. Arima H, Adachi H, Irie T, Uekama K. Improved drug delivery through the skin by hydrophilic β-cyclodextrins: Enhancement of anti-inflammatory effect of 4-bi- phenylylacetic acid in rats, Drug Invest. 1990; 2:155.
36. Arima H, Adachi H, Irie T, Uekama K, Pitha J. Enhancement of the anti-inflammatory effect of ethyl 4-biphenylylactic acetate ointment by β-cyclodextrin derivatives: Increased absorption and localized activations of the prodrug in rats, Pharm Res 1990; 7:1152.
37. Gerlóczy A, Antal S, Szejtli J. Percutaneous absorption of heptakis-(2,6-di-O-14C- methyl)-β-cyclodextrin in rats. In: Huber O, Szejtli J, eds. Proceedings of the 4th international Symposium on Cyclodextrins. Dordrecht, Boston, London: Kluwer 1988:415.
38. Vollmer U, Stoppie P, Mesens J, Wilffert B, Peters T. Hydroxypropyl β-cyclodex- trin in transdermal absorption in vivo in rats. In: Hedges AR, cd. Minutes of the 6th International Symposium on Cyclodextrins. Paris: Editions de Santé, 1992:535.
39. Montassier P. Inclusion de la trétinoïne dans les cyclodextrines, Thesis. 495, University of Paris XI, pharmaceutical sciences, Dec. 19, 1996.
40. Imamura K, Tsuchama Y, Tsunakawa H, Okamura K, Okamoto R, Harada K. (Mer- ushan Kk, Kogyo Gijutsuib). Cosmetics containing water-insoluble cyclodextrin polymers as scrubbing particles, JP 05,105,619 [93,105,619]. Feb. 14 1991.
41. Trinh T, Phan DV (Procter and Gamble Co.). Articles containing small particle size cyclodextrin for odor control, PCT Int Appl WO 94 22,501. March 31, 1993.
42. Ito K, Matsuda H (Shiseido Co. Ltd.). Aromatic deodorizing compositions, JP 07,241,333 [95,241,333]. March 4, 1994.
43. Trinh T, Cappel JP, Geis PA, McCarty ML, Pilosof D, Zwerdling SS. (Procter and Gamble Co. USA). Cyclodextrin solutions for odor control on surfaces, WO 96 04,937. Aug. 12, 1994.
44. Cho H, Torii M, Kanamori T (Lion Corp.). Deodorant controlling mouth odor, JP 63,264,516 [88,264,516]. April 20, 1987.
45. Imaoka KK, Sakamoto T, Gomi T (Lion Corp.). Dentifrices containing trancxamic acid, triclosan and menthyl acetate, JP 04,139,117 [92,139,117]. May 13, 1992.
46. Kishi T, Iwakawa M (Sekisui Chemical Co. Ltd.). Oral odor-controlling patch compositions, JP 63,280,014 [88,280,014]. May 12, 1987.
47. Kishi T (Sekisui Chemical Co. Ltd.). Adhesve deodorant tape for the control of underarm odor, JP 63,280,011 [88,280,011]. May 12, 1987.
48. Kishi T (Sekisui Chemical Co. Ltd.). Deodorant adhesive tapes for the control of underarm odor. JP 63,280,010 [88,280,010]. May 12, 1987.
49. Matsuda H, Ito K (Shiseido Co. Ltd.). Body deodorants containing hydroxyalky- latcd cyclodextrins, JP 03,284,616 [91,284,616]. Dec. 16, 1991.
50. Maekawa A (Sunstar Inc.). Antiperspirant aerosol compositions containing cyclodextrin, JP 03,170,415 [91,170,415]. Nov. 30, 1989.
51. Yamagata Y, Yoshibumi S (Lion Corp.). Hair preparations containing cationic surfactants and cyclodextrins, JP 62,267,220 [87,267,220]. May 15, 1986.
52. Saeki T, Morifuji T (Sekisui Plastics; Tanaka Narikazu, Japan). Moisturizer-containing cyclodextrin composite particles for cosmetics, JP 08,151,317 [96,151,317]. June 11, 1996.
53. Yagi Y, Sato M (Sanraku Co. Ltd.). Cosmetic packs containing methylated cyclodextrin, JP 01,193,209 [89,193,209]. Aug. 3, 1989.
54. Matsuda H, Ito K (Shiseido Co. Ltd.). Cosmetic packs containing hydroxyalkylated cyclodextrin, JP 03,287,512 [91,287,512]. March 31, 1991.
55. Jeanjean M, Sénégas N, Fabre В (Pierre Fabre Dermo-Cosmétique). Phytogenic dry shampoo comprising micronized powders, WO 96 00,563. June 28, 1994.
56. Natori Y, Nishida J (Lion Corp.). Cosmetics containing cyclodexrivatives for hair and skin, JP 05,194,153 [93,194,153]. August 3, 1993.
57. Shimada K, Ohe Y, Ohguni T, Kawano K, Ishii J, Nakamura T. Emulsifying proper-ties of α-, β- and γ-cyclodextrins. Nippon Shokuhin Kogyo Gakkaishi 1991; 38:16.
58. Hibi T, Kurahashi R, Sugimori K, Kamikama K (Nippon Tobacco Sangyo). Preparation of emulsions without emulsifiers, JP 06,128,149 [94,128,149]. May 10, 1994.
59. Laurent S, Graille J. Unpublished results. CIRAD, Montpellier, 1993.
60. Masuda T, Ishida S, Hashimoto S (Sunstar Inc.). Emulsions containing carboxymethyl cellulose sodium salt, JP 61,133,138 [86,133,138]. June 20, 1986.
61. Ogino S, Kamiya H (Kao Corp.). Manufacture of emulsions with methylated β- cyclodextrin for cosmetics, JP 63,194,726 [88,194,726]. Feb. 6 1987.
62. Matsuda H, Ito K (Shiseido Co. Ltd.). Emulsified cosmetics containing hydroxyalkylated cyclodextrins, JP 03,284,611 [91,284,611]. Dec. 18, 1991.
63. Oishi T, Nakanishi F, Yamamoto T (Hoyu Co. Ltd.). Hair dye powders containing cyclodextrin-dye inclusion compounds, EP 279,016. Aug. 24, 1988.
64. Rose D, Hoeffkes H (Henkel KGaA). Stabilization of oxidative hair dye precursors with cyclodextrins, DE 4,418,990. Dec. 7, 1995.
65. Hatae S, Nakajima K (Sansei Pharmaceutical Co. Ltd.). Skin whitening cosmetics, JP 61,109,705 [86,109,705]. Nov. 1, 1984.
66. Hatae S (Sansei Pharmaceutical Co. Ltd.). Use of kojic acid or its β-cyclodextrin inclusion complex for the treatment of elastosis, EP 207,499. July 2, 1985.
67. Hatae S Nakajima K (Sansei Pharmaceutical Co. Ltd.). Skin compositions containing cyclodextrin inclusion compound of kojic acid, JP 63,08,311 [88,08,311]. Jan. 14, 1988.
68. Motono M (Sansei Pharmaceutical Co. Ltd.). Discoloration prevention in cosmetics containing kojic acid (derivatives) by UV absorbers, β-cyclodextrin, and EDTA, JP 63,188,609 [88,188,609]. Aug. 4, 1988.
69. Motono M (Sansei Pharmaceutical Co. Ltd.). Skin lightening compositions containing maltosyl cyclodextrins and kojic acid, J. 63,208,510 [88,208,510]. Aug. 30, 1988.
70. Tseng CY, Yu ZR, Li CF. Preparation of royal jelly and property characterization of the products during storage. Zhongguo Nongye Huaxue Huizhi 1994; 32:113.
71. Sanraku-Ocean Co. Ltd. Stable royal jelly powder, JP 60. 37,942 [85 37,]. Aug. 9, 1983.
72. Komiyama T. Oxidizing agents for hair wave-setting, JP 04,356,412 [92,356,412]. Dec. 10, 1992.
73. Kubo S, Nakamura F (Shiseido Co. Ltd.), Low-odor permanent wave preparations, DE 3,416,075. Oct. 31, 1985.
74. Iwao S, Kuwana H (Lion Corp.). Hair-cosmetic composition containing a cationic polymer and a cyclodextrin for inhibition of perm odor, EP 246,090. Nov. 19, 1987.
75. Sato M, Yagi Y, Ishikura T (Sanraku Co. Ltd.). Methylated cyclodextrins in reduciing agents for setting hair waves, JP 62,161,714 [87,161,714]. July 18 1987.
76. Takeuchi K, Ichikawa S (Fujinaga Pharmaceutical Co. Ltd.). Odorless and colorless skin preparations containing tar and cyclodextrin, JP 01,287,042 [89,287,042]. May 13, 1988.
77. Yorozu H, Okawa W (Kao Corp.). Bath preparations containing enzymes, sulfite salts, and inclusion compounds. JP 03,271,218 [91,271,218]. March 19, 1990.
78. Lentini PJ, Zecchino JR (Estee Lauder Inc.). Skin tanning compositions containing cyclodextrins, WO 95 22,960. Aug. 31, 1995.
79. Ogino S, Hirota H (Kao Corp.). Liquid shampoos containing menthol and β-cyclodextrin, JP 61,197,509 [86,197,509]. Feb. 27, 1985.
80. Shimada T, Mukogasa K, Gomi T, Yokoo T (Lion Corp.). Oral compositions containing cationic bactericides and cyclodextrin, JP 07,101,842 [95,101,842]. April 18, 1995.
81. Ito K, Nagai I (Shiseido Co. Ltd.). Cosmetic containing menthol derivatives, JP 06,329,528 [94,329,528]. May 20, 1993.
82. Oshino K, Egichi Y (Kao Corp.), Effervescent mouth-refreshing solid compositions containing exothermic agents and 1-mcnthol inclusion compound, JP 07,238,008 [95,238,008]. Jan. 7, 1994.
83. Buschmann HJ, Knittel D, Schollmeycr E. α-Cyclodextrin as a perfume oil complexing agent. Partnern Kosmet 1991; 72:586.
84. Matsuda H, Yomogida K, Miyazawa K, Uchikawa K, Taniguchi T, Tanaka M, Taki A, Sumiyoshi H, Uekama K. Release control of fragrance materials by 2- hydroxypropyl-β-cyclodextrin. In: Hedges AR, ed. Minutes of the 6th International Symposium on cyclodextrins Chicago, April 21–24,1992. Paris: Editions de Santé, 1992, p. 516.
85. Matsuda H, Ito K, Tanaka M, Sumiyoshi H. Inclusion complexes of various fragrance materials with 2-hydroxypropyl-β-cyclodextrin. STP Pharma Sci 1991; 1: 211.
86. Matsuda H, Ito K, Fujiwara Y, Tanaka M, Taki A, Uejima O, Sumiyoshi H. Complexation of various fragrance materials with 2-hydroxypropyl-β-cyclodextrin. Chem Pharm Bull 1991; 39:827.
87. Matsuda H, Ito K, Taniguchi K, Tanaka M, Uekama K. Application of 2-hydroxypropyl-β-cyclodextrin to perfumes and cosmetics. Proceedings of the 7th International Cyclodextrins Symposium. Tokyo, Japan, 1994:516–519.
88. Lchncr SJ, Müller BW, Seydel JK. Interactions between p-hydroxybenzoic acid esters and hydroxypropyl-β-cyclodextrin and their antimicrobial effect against Candida albicans, Int J Pharm 1993; 93:201.
89. Loftsson T, Stefánnsdóttir Ó, Fridriksdóttir Ö, Gudmundsson Ö. Interactions between preservatives and 2-hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 1992; 18:1477.
90. Matsuda H, Ito K, Sato Y, Yoshizawa D, Tanaka M, Taki A, Sumiyoshi H, Utsuki T, Hirayama F, Uekama K. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-β-cyclodextrins: On changes in solubility and antimicrobial activity, Chem Pharm Bull 1993; 41:1448.
91. Citernesi U, Sciacchitano M. Cyclodextrins in functional dermocosmctics, Cosmet Toiletries 1995; 110(3):53.
92. Ogino S, Kamya H (Kao Corp.). Methylated β-cyclodextrin-containing skin or hair lotion preparations with no irritation to the skin, JP 63,192,706 [88,192,706]. Feb. 6, 1987.
93. Ogawa H (Lion Corp.). Bath preparations containing water-soluble sulfides and fragrances, JP 02 11,512 [90 11,512]. June 30, 1988.
94. Hasebe K, Ando Y, Chikamatsu Y, Hayashi K. Bath preparation containing aro- matic essential oil-cyclodextrin inclusion compounds, JP 63 08,309 [88 08,309]. June 26, 1986.
95. Sato M, Yagi Y, Ishikura T. Bath preparations containing perfume-methylated cyclodextrin inclusion compounds, JP 62,161,720 [87,161,720]. Jan. 13, 1986.
96. Sato H (Sunstar Inc.). Toothpastes containing a flavor that changes to a different flavor during tooth brushing, JP 61,218,513 [86,218,513]. March 23, 1985.
97. Terajima Y, Tokuda K, Nakamura S. (Shiseido Co. Ltd.). Cosmetics containing fragrant compound-cyclodextrin inclusion compounds coated with oils, JP 63 35,517 [88 35,517]. July 31, 1986.
98. Szejtli J, Szente L, Kulcsar G, Kemoczy LZs. β-cyclodextrin complexes in talc powder compositions, Cosmet Toiletries 1986; 101:74.
99. Tanaka M, Matsuda H, Sumiyoshi H, Arima H, Hirayama F, Uekama K, Tsuchiya S. 2-hydroxypropylated cyclodextrins as a sustained-release carrier for fragrance materials. Chem Pharm Bull 1996; 44:416.
100. Ishii K, Yoshioka T, Takada S (Shiseido Co. Ltd.). Perfumes containing saccharides and organic substances with specified inorganic balance (IOB), JP 08,176,587 [96,176,587]. Dec. 27, 1994.
101. Yamamoto K, Hikichi S, Kitaoka K, Hara K, Tomizawa N. Perfumes for underarm applications, JP 08,183,719 [96,183,719]. Dec. 28, 1994.
102. Chikahisa N. Perfume-containing thermosetting resin moldings, JP 01,279,973 [89,279,973]. Oct. 26 1987.
103. Chen Z, Zhuang Z, Li G, Tan Z. Preparation and clinical effect of inclusion of retinoic acid-β-cyclodextrin. Guangdong Yaoxueyuan 1996; 12(2):85.
104. Zhuang Z, Li G, Shi X. Study on the stability of retinoic acid-β-cyclodextrin inclusion. Zhongguo Yiyuan Yaoxue Zazhi 1995; 15:362.
105. Wadstein J, Samuelsson M. Vitamin A-cyclodextrin complex for prevention of skin aging, WO 94 21,225. Sept. 29, 1994.
106. Matsuda H, Ito K, Taki A, Uejima О (Shiseido Co. Ltd.). Cosmetic composition containing inclusion product with hydroyalkylated cyclodextrin for preventing skin roughness, EP 366,154. Oct. 28, 1988.
107. Kawamura K, Takahashi K, Kamiyama F, (Sekusui Cemical Co. Ltd.). Dispersion of higher fatty acids and their esters in water and effect of cyclodextrin on the dispersion, JP 62 96,432 [87 96,432]. May 2, 1987.
108. Kuwabara N, Ohu S (Ensuiko Sugar Refining Co. Ltd.). Bath preparations containing cyclodextrin-squalane inclusion compounds, JP 63,190,819 [88,190,819]. Feb. 4, 1987.
109. Shibauchi I, Nakamura K. Bath preparation containing cyclodextrin inclusioncompounds of milk or milk products, JP 60,181,013 [85,181,013]. Feb. 27, 1985.
110. Shibauchi I. Bath preparation containing cyclodextrin-milk component inclusion compound, JP 61,286,318 [86,286,318]. June 13, 1985.
111. Yorozu H, Eguchi Y. Cyclodextrins containing carbone dioxide for use as bath additive, JP 61,277,610 [86,277,610]. June 3, 1985.
112. Navarro R, Delaunois M (Pierre Fabre Dermo-Cosmétique), Minoxidil-based hair care composition, WO 95 25,500. Sept. 28, 1995.
113. Kawakami M, Sakamoto M, Kumazawa T (Kyushin Seiyaku Co. Ltd.), Mouthwashes containing iodine-maltocyclodextrin inclusion compound as a microbicide with high water-solubility, JP 63,150,217 [88,150,217]. Dec. 16, 1986.